ClinicalTrials.Veeva

Menu

Cross-sectorial Use of Patient-Reported Outcomes in Chronic Degenerative Shoulder Conditions (C-PRO)

U

University Hospital, Gentofte, Copenhagen

Status

Invitation-only

Conditions

Shoulder Bursitis
Shoulder Osteoarthritis
Shoulder Frozen
Rotator Cuff Syndrome of Shoulder and Allied Disorders
Rotator Cuff Syndrome
Shoulder Capsulitis
Shoulder Disease
Shoulder Impingement Syndrome
Shoulder Impingement

Treatments

Other: Systematic use of patient reported outcome measures in clinical work with the patients

Study type

Interventional

Funder types

Other

Identifiers

NCT06435494
H-23039139

Details and patient eligibility

About

This research project aims to test if systematic (extensive) use of patient-reported outcomes across treatment boundaries can

  1. improve patients' and health professionals' understanding of individual patients' conditions and health changes,
  2. improve indications for treatment,
  3. strengthen patient empowerment, and
  4. reduce patients' utilization of health services.

The study will be performed in the particular context of patients with chronic degenerative conditions of the shoulder. These patients are characterized by contact with numerous health professionals from different health sectors, such as general practitioner, physiotherapists and surgical referral centres, which challenges coherence and communication for the individual treatment decisions. The research project will be performed as a randomized controlled trial (RCT) with a 1-year inclusion period and two years of follow-up.

Enrollment

1,000 estimated patients

Sex

All

Ages

18 to 120 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • shoulder pain with no acute trauma

Exclusion criteria

  • Age <18 years
  • Non-Danish citizenship
  • Unable to understand written or spoken Danish
  • Inability to master electronic means of communication and/or not having an electronic communication (E-boks)
  • Employee at participating centre or other relation to participating health professionals that might affect independent consent
  • Psychiatric conditions, mental conditions and substance abuse that might affect the ability to provide informed consent or responding to PROMs
  • Disseminated malignant condition, other serious medical conditions or other life crisis where the focus on a shoulder research project is unreasonable
  • Already included in the study with the contralateral shoulder

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

1,000 participants in 2 patient groups

Intervention
Experimental group
Description:
All patients will be asked to complete a number of questionaires: EQ5D-5L, a study specific questionaire (designed specifically for this study) and a shoulder-disease-specific questionaire (the Oxford Shoulder Score). For patients in the intervention group, the results of the questionaires will be accessable for patient and health-care professionals and will be used to illustrate the problems, make a prognostic model for the specific patient based on previous PRO results from other patients and will be used in monitoring the treatment of the patient.
Treatment:
Other: Systematic use of patient reported outcome measures in clinical work with the patients
Control
No Intervention group
Description:
All patients will be asked to complete a number of questionaires: EQ5D-5L, a study specific questionaire and a shoulder-disease-specific questionaire. For patients int he control group, this will be collected, but not accessed or used during the treatment of the patient. The data will be used in the final analyses of the study.

Trial contacts and locations

6

Loading...

Central trial contact

Anne Marie Nyholm, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems